TY - JOUR
T1 - Key factors for overcoming psychological insulin resistance
T2 - A qualitative study in Japanese people with type 2 diabetes
AU - Okazaki, Kentaro
AU - Takahashi, Noriyuki
AU - Shingaki, Tomotaka
AU - Perez-Nieves, Magaly
AU - Stuckey, Heather
N1 - Funding Information:
We thank the participants and the study personnel who participated in this study. This study was sponsored by Eli Lilly and Company , USA and Boehringer Ingelheim , Germany. All authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work as a whole, and have given their approval for this manuscript to be published. Medical writing and editorial support was provided by Lisa Cossens and Antonia Baldo of Syneos Health, funded by Eli Lilly Japan K.K. , Japan.
Publisher Copyright:
© 2022 The Authors
PY - 2022/6
Y1 - 2022/6
N2 - Aims: We report the key factors that motivate reluctant Japanese people with type 2 diabetes (T2D) to initiate insulin treatment. Methods: Participants were asked questions pertaining to 2 primary areas of exploration in a concurrent mixed methods approach: (a) understanding people's thoughts and perceptions before and after insulin initiation and any related factors; and (b) exploring the reasons behind people's responses. Data were analyzed using Steps for Coding and Theorization. Results: Participant responses broadly related to 3 themes which influence insulin initiation; 1. Advice from a health care provider (HCP) that insulin is an appropriate treatment; 2. Demonstration by HCPs on how to use the insulin pen/needle and the injection process; and 3. Resignation/surrender/acceptance of insulin, where participants felt there was no other choice but to commence insulin. Conclusions: Based on the 3 identified themes, it is important for HCPs to explain the benefits of insulin and demonstrate and explain the injection procedure to reluctant Japanese people with T2D. We also identified resignation/surrender/acceptance of insulin as a reason for treatment commencement. This study provides important information to assist HCPs in helping reluctant Japanese people with T2D to initiate basal insulin therapy.
AB - Aims: We report the key factors that motivate reluctant Japanese people with type 2 diabetes (T2D) to initiate insulin treatment. Methods: Participants were asked questions pertaining to 2 primary areas of exploration in a concurrent mixed methods approach: (a) understanding people's thoughts and perceptions before and after insulin initiation and any related factors; and (b) exploring the reasons behind people's responses. Data were analyzed using Steps for Coding and Theorization. Results: Participant responses broadly related to 3 themes which influence insulin initiation; 1. Advice from a health care provider (HCP) that insulin is an appropriate treatment; 2. Demonstration by HCPs on how to use the insulin pen/needle and the injection process; and 3. Resignation/surrender/acceptance of insulin, where participants felt there was no other choice but to commence insulin. Conclusions: Based on the 3 identified themes, it is important for HCPs to explain the benefits of insulin and demonstrate and explain the injection procedure to reluctant Japanese people with T2D. We also identified resignation/surrender/acceptance of insulin as a reason for treatment commencement. This study provides important information to assist HCPs in helping reluctant Japanese people with T2D to initiate basal insulin therapy.
UR - http://www.scopus.com/inward/record.url?scp=85125732035&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85125732035&partnerID=8YFLogxK
U2 - 10.1016/j.pcd.2022.02.009
DO - 10.1016/j.pcd.2022.02.009
M3 - Article
C2 - 35256314
AN - SCOPUS:85125732035
SN - 1751-9918
VL - 16
SP - 411
EP - 416
JO - Primary Care Diabetes
JF - Primary Care Diabetes
IS - 3
ER -
